We are live on ! Find out more
BCLI

BRAINSTORM CELL THERAPUTC
BCLI

Delisted

BCLI was delisted on the 17th of July, 2025.

Back to rankings

5 hedge funds and large institutions have $1.73K invested in BRAINSTORM CELL THERAPUTC in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.97% less ownership

Funds ownership: 3.99% → 0.02% (-4%)

85% less funds holding

Funds holding: 34 → 5 (-29)

99% less capital invested

Capital invested by funds: $264K → $1.73K (-$262K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 29

Holders
5
Holders Change
-29
Holders Change %
-85.29%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
29
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
-$61.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$31.1K
3
GCM
Gunderson Capital Management
South Carolina
-$29.1K
4
BlackRock
BlackRock
New York
-$28.2K
5
LWM
Liberty Wealth Management
California
-$25.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
1
Osaic Holdings
Arizona
$1.35K – – –
BSB
2
Bangor Savings Bank
Maine
$188 – – –
VWA
3
VSM Wealth Advisory
Maryland
$85 – – –
SPIA
4
Steward Partners Investment Advisory
New York
$80 – – –
DJSG
5
D.J. St. Germain
Massachusetts
$23 – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$61.1K -54,582 Closed
Vanguard Group
7
Vanguard Group
Pennsylvania
– -$31.1K -27,724 Closed
GCM
8
Gunderson Capital Management
South Carolina
– -$29.1K -25,950 Closed
BlackRock
9
BlackRock
New York
– -$28.2K -25,172 Closed
LWM
10
Liberty Wealth Management
California
– -$25.4K -22,666 Closed
WCG
11
Weaver Consulting Group
California
– -$17.5K -15,623 Closed
UBS Group
12
UBS Group
Switzerland
– -$13.9K -12,380 Closed
TCM
13
Traynor Capital Management
Pennsylvania
– -$12.2K -11,000 Closed
LPL Financial
14
LPL Financial
California
– -$12K -10,698 Closed
AIP
15
Almanack Investment Partners
Pennsylvania
– -$11.2K -10,000 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$6.5K -5,803 Closed
Raymond James Financial
17
Raymond James Financial
Florida
– -$5.78K -5,158 Closed
HI
18
Harbour Investments
Wisconsin
– -$3.99K -3,559 Closed
Wells Fargo
19
Wells Fargo
California
– -$1.5K -1,338 Closed
Citigroup
20
Citigroup
New York
– -$743 -663 Closed
AWM
21
Activest Wealth Management
Florida
– -$374 -334 Closed
SS
22
SBI Securities
Japan
– -$244 -218 Closed
Jones Financial Companies
23
Jones Financial Companies
Missouri
– -$229 -216 Closed
Bank of America
24
Bank of America
North Carolina
– -$152 -136 Closed
CA
25
Clearstead Advisors
Ohio
– -$112 -100 Closed
1
2

BCLI Hedge Fund Activity: Q3 2025 in Review

5 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in BRAINSTORM CELL THERAPUTC (BCLI) for Q3 2025, worth a combined $1.73K — down 99% from $264K a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of BCLI and 0 opened new positions — a net loss of 29 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Geode Capital Management, exiting entirely with an estimated $61.1K sold.

  • 5 institutional investors held BRAINSTORM CELL THERAPUTC (BCLI) as of Q3 2025, down from 34 in Q2 2025.
  • Funds reported $1.73K of BRAINSTORM CELL THERAPUTC stock for Q3 2025, down 99% quarter-over-quarter.
  • 0 funds opened new BRAINSTORM CELL THERAPUTC positions in Q3 2025 and 29 closed out, a net change of -29 holders.
  • The largest BRAINSTORM CELL THERAPUTC seller in Q3 2025 was Geode Capital Management, an estimated $61.1K sold.

Based on aggregated 13F filings for Q3 2025.